LFM
JAZZ icon

Lumina Fund Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Lumina Fund Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-32,500
Closed -$5.36M – 50
2014
Q1 		$5.36M Buy
+32,500
New +$4.89M 0.63% 14

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Lumina Fund Management's JAZZ Position: Q1 2017 in Review

Lumina Fund Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2017, closing a stake of 30,000 shares — an estimated $3.27M sold.

Lumina Fund Management first reported a position in JAZZ in Q3 2015 and held it in 5 quarters. The position peaked at $3.68M in Q3 2015. 306 funds tracked by Wall St. Rank hold JAZZ as of Q1 2017.

  • Lumina Fund Management reported no remaining Jazz Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Lumina Fund Management sold 30,000 Jazz Pharmaceuticals shares in Q1 2017, an estimated $3.27M.
  • Lumina Fund Management first reported a position in Jazz Pharmaceuticals in Q3 2015 and held it in 5 quarters.
  • Lumina Fund Management's Jazz Pharmaceuticals position peaked at $3.68M in Q3 2015.
  • 306 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2017.

Based on Lumina Fund Management's 13F filing for Q1 2017, filed 12 May 2017.